Recursion Pharmaceuticals, Inc.(RXRX)NASDAQ
Fundamental Analysis & Financials
Valuation Snapshot
What the multiples imply about expectations
The market considers the company to be a smaller player with a significant market presence. At current multiples, it trades fairly valued—reflecting market expectations.
Valuation Metrics
Ratios and multiples
Financial Health
Liquidity and leverage
The company's financial health appears moderate. Moderate ROE and moderate ROA reflect reasonably efficient capital use. Debt is elevated but represents structural leverage for shareholder return strategy (buybacks) rather than operational stress.
Valuation Multiples
Current valuation metrics
Quarterly Earnings History
Recent quarterly financial performance and trends
| Quarter | Revenue | Net Income | Gross Profit | EPS (Basic) | EPS (Diluted) | Gross Margin | Net Margin |
|---|---|---|---|---|---|---|---|
| Q3 2025(Latest) | $4.98M | $-162.25M | $-9.70M | $-0.36 | $-0.36 | -19474.2% | -3256.1% |
| Q2 2025 | $19.10M | $-171.90M | $-1.06M | $-0.41 | $-0.41 | -553.8% | -899.8% |
| Q1 2025 | $14.82M | $-202.49M | $-7.01M | $-0.50 | $-0.50 | -4731.4% | -1366.5% |
| Q4 2024 | $4.51M | $-178.91M | $-8.28M | $-0.53 | $-0.53 | -18361.8% | -3966.0% |
Key Insights:
- Revenue decreased by 73.9% from previous quarter
- Net margin of -3256.1% indicates low profitability
- EPS improved by 12.2% quarter-over-quarter
Financial Efficiency
Utilization and collections performance
Asset Turnover 0.03 indicates low efficiency. Working Capital Turnover 0.08 is moderately efficient. ROIC -67.4% highlights weak capital returns.
Efficiency Metrics
Profitability & Growth
Margins and earnings power
Efficiency Performance Matrix
4-quadrant analysis of operational efficiency vs profitability
Efficiency vs Profitability Quadrants
High Margin
Low Margin
High Margin
Low Margin
Efficiency Analysis
Asset Turnover
Receivables Turnover
Working Capital
Overall Efficiency Score
Operationally weak with structural efficiency and margin issues
⚠️ Thresholds are benchmark-based heuristics derived from long-term industry averages, not strict valuation rules.
• Bubble size represents ROIC magnitude
• Green (Optimal): Excellent efficiency-profitability balance
• Blue (Efficiency-Driven): High turnover, room to improve margins
• Yellow (Margin-Driven): Strong margins, opportunity to improve efficiency
• Red (Weak Operations): Areas needing improvement on both dimensions
Market Data & Share Structure
Comprehensive valuation metrics and ownership breakdown
Market Data & Capitalization
Share Statistics & Ownership
Profitability Margin Pyramid
Hierarchical view of margin compression from revenue to net income
Margin Hierarchy by Profitability Level
Margin Analysis
Total Revenue
Gross Profit
EBITDA
Net Income
Margin Quality Assessment
Thin margins indicating potential profitability challenges
• Larger circles represent higher dollar amounts
• Margin percentages show profitability at each level
• Blue: Revenue base
• Green: Gross profitability
• Yellow: Operating performance
• Red: Net profitability
Operating Cash & Liquidity
Core cash generation and short-term solvency
Cash Flow Analysis
Operating Cash Flow (TTM)
$-441.16M
Cash from core operations
Free Cash Flow (TTM)
$-227.07M
Available after capex
Financial Position & Liquidity
Current Ratio
4.60
Healthy
Quick Ratio
4.39
Strong
Net Cash
$577.46M
Net creditor
Total Cash
$659.84M
Balance sheet cash
Total Debt
$82.37M
Outstanding borrowings
Dividends & Shareholder Returns
Policy stance and implications
The company does not currently pay a regular dividend — prioritizing reinvestment for growth. This makes it attractive for growth investors, while income-oriented investors may prefer peers with dividend payouts.